DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2251176/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2251176 Apr 05, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. 0

https://www.nrn.com/consumer-trends/green-smoothies-hearty-drink-health-halo Apr 04, 2024 - Green smoothies can vary widely in ingredients, but the core component is usually a leafy green vegetable. It’s usually spinach or kale, but it could also include the fleshy leaves of the aloe vera plant or other nutrient-dense greens. Those are puré 0

https://www.zacks.com/stock/news/2246796/fate-therapeutics-fate-down-8-since-last-earnings-report-can-it-rebound?cid=CS-ZC-FT-realtime_blog-2246796 Mar 27, 2024 - Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. 0

https://www.zacks.com/stock/news/2228804/compared-to-estimates-halozyme-therapeutics-halo-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2228804 Feb 20, 2024 - The headline numbers for Halozyme Therapeutics (HALO) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.zacks.com/stock/news/2226264/exact-sciences-exas-may-report-negative-earnings-know-the-trend-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2226264 Feb 14, 2024 - Exact Sciences (EXAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2225551/halozyme-therapeutics-halo-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2225551 Feb 13, 2024 - Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2213449/why-halozyme-therapeutics-halo-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2213449 Jan 22, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. 0

https://www.zacks.com/stock/news/2205005/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2205005 Jan 03, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. 0

https://www.zacks.com/stock/news/2198208/3-reasons-growth-investors-will-love-halozyme-therapeutics-halo?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2198208 Dec 14, 2023 - Halozyme Therapeutics (HALO) possesses solid growth attributes, which could help it handily outperform the market. 0

https://www.zacks.com/stock/news/2195473/why-halozyme-therapeutics-halo-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2195473 Dec 08, 2023 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. 0